Every patient is asked once at diagnosis whether researchers may contact them
At diagnosis, people would be asked a single question: may we contact you about research that fits your cancer? Those who say yes would be findable by trial teams without repeated cold approaches.
A health-system-level consent-to-contact register, recorded in the EHR at diagnosis, allowing approved trial teams to approach registered patients whose records match a protocol. The UK's Be Part of Research and Scotland's SHARE register are precedents; the idea is to make the question a mandatory element of cancer diagnosis pathways and to link the register to matching tools.
- Trials enrol too few, too slowly · Fewer than one in ten adults with cancer joins a trial. Trials close for lack of patients, not lack of ideas.
Pages like this
not linked directly; found by shared links- InstitutionIrish Cancer Society
Shares Trials enrol too few, too slowly, Cancer Research UK.
- IdeaOne national master contract and budget template for all cancer trials
Shares Trials enrol too few, too slowly, Cancer Research UK.
- IdeaOne standing umbrella trial for all rare cancers in a country
Shares Trials enrol too few, too slowly, Cancer Research UK.
- IdeaA national platform trial that every ctDNA-positive patient can join
Shares Trials enrol too few, too slowly, Cancer Research UK.